Differential transgene expression in brain cells in vivo and in vitro from AAV-2 vectors with small transcriptional control units.

Adeno-associated- (AAV) based vectors are promising tools for gene therapy applications in several organs, including the brain, but are limited by their small genome size. Two short promoters, the human synapsin 1 gene promoter (hSYN) and the murine cytomegalovirus immediate early promoter (mCMV), were evaluated in bicistronic AAV-2 vectors for their expression profiles in cultured primary brain cells and in the rat brain. Whereas transgene expression from the hSYN promoter was exclusively neuronal, the murine CMV promoter targeted expression mainly to astrocytes in vitro and showed weak transgene expression in vivo in retinal and cortical neurons, but strong expression in thalamic neurons. We propose that neuron specific transgene expression in combination with enhanced transgene capacity will further substantially improve AAV based vector technology.

[1]  G. Sandford,et al.  Rat cytomegalovirus has a unique immediate early gene enhancer. , 1996, Virology.

[2]  F. Graham,et al.  Comparison of the human versus murine cytomegalovirus immediate early gene promoters for transgene expression by adenoviral vectors. , 1997, The Journal of general virology.

[3]  R. Samulski,et al.  Selective and rapid uptake of adeno-associated virus type 2 in brain. , 1998, Human gene therapy.

[4]  M. Dragunow,et al.  Quantitative comparison of expression with adeno-associated virus (AAV-2) brain-specific gene cassettes , 2001, Gene Therapy.

[5]  B. Byrne,et al.  Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield , 1999, Gene Therapy.

[6]  B. Carter,et al.  Adeno-associated virus vectors , 1992, Current Biology.

[7]  P. Fan,et al.  Quantitative analysis of the packaging capacity of recombinant adeno-associated virus. , 1996, Human gene therapy.

[8]  R. Samulski,et al.  Cross-Packaging of a Single Adeno-Associated Virus (AAV) Type 2 Vector Genome into Multiple AAV Serotypes Enables Transduction with Broad Specificity , 2002, Journal of Virology.

[9]  J. Uney,et al.  Adenoviral-mediated, high-level, cell-specific transgene expression: a SYN1-WPRE cassette mediates increased transgene expression with no loss of neuron specificity. , 2002, Molecular therapy : the journal of the American Society of Gene Therapy.

[10]  S. Kügler,et al.  Transduction of axotomized retinal ganglion cells by adenoviral vector administration at the optic nerve stump: an in vivo model system for the inhibition of neuronal apoptotic cell death , 1999, Gene Therapy.

[11]  S. Kügler,et al.  Human synapsin 1 gene promoter confers highly neuron-specific long-term transgene expression from an adenoviral vector in the adult rat brain depending on the transduced area , 2003, Gene Therapy.

[12]  M. Bähr,et al.  Transection of the optic nerve in rats: studying neuronal death and survival in vivo. , 2001, Brain research. Brain research protocols.

[13]  R. Klein,et al.  Adeno-associated virus vectors: activity and applications in the CNS , 2000, Journal of Neuroscience Methods.

[14]  S. Kügler,et al.  Neuron-Specific Expression of Therapeutic Proteins: Evaluation of Different Cellular Promoters in Recombinant Adenoviral Vectors , 2001, Molecular and Cellular Neuroscience.

[15]  D. Grimm,et al.  Novel tools for production and purification of recombinant adenoassociated virus vectors. , 1998, Human gene therapy.

[16]  J. Feldon,et al.  Influence of promoter and WHV post-transcriptional regulatory element on AAV-mediated transgene expression in the rat brain , 2000, Gene Therapy.

[17]  P. Lowenstein,et al.  Strong promoters are the key to highly efficient, noninflammatory and noncytotoxic adenoviral-mediated transgene delivery into the brain in vivo. , 2000, Molecular therapy : the journal of the American Society of Gene Therapy.

[18]  G. Paxinos,et al.  The Rat Brain in Stereotaxic Coordinates , 1983 .

[19]  M. Bähr.  Live or let die – retinal ganglion cell death and survival during development and in the lesioned adult CNS , 2000, Trends in Neurosciences.